Clinical Trials Update: Dec. 22, 2006
Chronic Lymphocytic Leukemia Idiopathic Short Stature Schizophrenia and Schizoaffective Disorders
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Chronic Lymphocytic Leukemia
Volunteers 18 or older with B-cell chronic lymphocytic leukemia who have not been treated for the disease with a cell-depleting aim may be eligible for this clinical trial.
The research sites are in California, New York, and Texas.
Idiopathic Short Stature
This study will evaluate a drug for treating idiopathic short stature (ISS) in children who don't grow to a height within normal range, but who are otherwise physically normal. Children without chronic disease ages 3-9 for girls and ages 3-10 for boys may qualify.
The research site is in New Hyde Park, NY.
Schizophrenia and Schizoaffective Disorders
This study will evaluate an investigational medication to treat schizophrenia and schizoaffective disorder. Candidates at least 18 who were diagnosed a year ago or more with schizophrenia or schizoaffective disorder, have not been hospitalized for the condition within the last three months, and are taking either Seroquel (quetiapine) OR Risperdal (risperidone) and still have symptoms may be included.
The research site is in Stanford, Calif.
Copyright 2006 Thomson CenterWatch. All rights reserved.